Hinyokika Kiyo. 1988 Aug;34(8):1371-5.

[Experience with combination chemotherapy consisting of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) in advanced urothelial cancer].

[Article in Japanese]

Nishio Y, Shirahase T, Shichiri Y, Habuchi T, Matsuda T, Nishimura K, Hida S, Okada Y, Yoshida O.

Source

Department of Urology, Faculty of Medicine, Kyoto University.

Abstract

The M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) regimen was used to treat 6 patients with metastatic transitional cell carcinoma of the urothelial tract. Three patients showed a partial response, all of them were made surgically disease free. Two of them are still alive 1 year and for 6 months after surgery with no evidence of disease and one other died of disease 11 months after surgery. The response in one case was no change and that in two others was a progressive disease. From our experience, we suggest that treatment with M-VAC is effective but that surgery after M-VAC appears essential for the successful management of the patients with metastatic transitional cell carcinoma of the urothelial tract.

PMID:: 3195405; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin chemotherapy for advanced urothelial cancers. [Cancer Chemother Pharmacol. 1992]
Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin chemotherapy for advanced urothelial cancers.
Ogawa T, Gotoh A, Takenaka A, Hara I, Gohji K, Arakawa S, Matsumoto O, Kamidono S. Cancer Chemother Pharmacol. 1992; 30 Suppl:S66-71.
Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. [J Urol. 1985]
Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium.
Sternberg CN, Yagoda A, Scher HI, Watson RC, Ahmed T, Weiselberg LR, Geller N, Hollander PS, Herr HW, Sogani PC. J Urol. 1985 Mar; 133(3):403-7.
Review Chemotherapy of urothelial tract tumors. [Cancer. 1987]
Review Chemotherapy of urothelial tract tumors.
Yagoda A. Cancer. 1987 Aug 1; 60(3 Suppl):574-85.
Review [Outcome of treatment with surgical resection of the remaining tumor after modified M-VAC treatment for advanced urothelial carcinoma]. [Hinyokika Kiyo. 2005]
Review [Outcome of treatment with surgical resection of the remaining tumor after modified M-VAC treatment for advanced urothelial carcinoma].
Narita S, Nakano M, Matsuzaki M, Watanabe J, Morikawa H, Murata H, Oda H, Komatsu H. Hinyokika Kiyo. 2005 Mar; 51(3):155-8.
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced urothelial cancer. [Cancer Chemother Pharmacol. 1992]
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced urothelial cancer.
Ueki O, Hisazumi H, Uchibayashi T, Naito K, Tajiri S, Takemae K, Kawaguchi K, Kameda K, Nishino A, Nango C. Cancer Chemother Pharmacol. 1992; 30 Suppl:S72-6.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

[Experience with combination chemotherapy consisting of methotrexate, vinblastin...
[Experience with combination chemotherapy consisting of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) in advanced urothelial cancer].
Hinyokika Kiyo. 1988 Aug ;34(8):1371-5.

PubMed
Not all "occult" papillary carcinomas are "minimal".
Not all "occult" papillary carcinomas are "minimal".
Surgery. 1988 Dec ;104(6):971-6.

PubMed
Biomechanical considerations in the surgical management of cervical spondylotic ...
Biomechanical considerations in the surgical management of cervical spondylotic myelopathy.
Spine (Phila Pa 1976). 1988 Jul ;13(7):856-60.

PubMed
Proofreading of the codon-anticodon interaction on ribosomes.
Proofreading of the codon-anticodon interaction on ribosomes.
Proc Natl Acad Sci U S A. 1977 Jan ;74(1):198-202.

PubMed
Structure and chromosomal localization of the functional intronless human JUN pr...
Structure and chromosomal localization of the functional intronless human JUN protooncogene.
Proc Natl Acad Sci U S A. 1988 Dec ;85(23):9148-52.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

[Experience with combination chemotherapy consisting of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) in advanced urothelial cancer].

Source

Abstract

Publication Types, MeSH Terms, Substances, Supplementary Concepts

Publication Types

MeSH Terms

Substances

Supplementary Concepts

LinkOut - more resources

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information